Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series
Top Cited Papers
Open Access
- 1 January 2004
- Vol. 53 (1) , 34-37
- https://doi.org/10.1136/gut.53.1.34
Abstract
Background:Helicobacter pylori plays a decisive role in the pathogenesis of gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT), and eradication therapy has become a widely accepted initial treatment of stage I disease. Objective: To determine the long term outcome of patients undergoing exclusive H pylori eradication therapy. Design: A prospective series of patients with newly diagnosed marginal zone B cell lymphoma of MALT. Setting: Multicentre study in Germany and Austria. Patients: Ninety five patients; 90 of these (five lost to follow up) with a mean age of 54.3 (27–85) years were followed up for at least 12 months. Intervention: Complete staging work up revealing stage I disease and H pylori infection. Patients received triple therapy (OMC: omeprazole 20 mg twice daily, metronidazole 400 mg twice daily, and clarithromycin 250 mg twice daily; or OAC: omeprazole 20 mg twice daily, amoxycillin 1000 mg twice daily, and clarithromycin 500 twice daily) for one week. Results: Median follow up was 44.6 (12–89) months. H pylori was successfully eradicated in 88 patients (98%); in two patients eradication therapy failed. Long term outcome was characterised by complete regression of lymphoma in 56 patients (62%), minimal residual disease in 17 patients (18%), partial remission in 11 patients (12%), no change in four patients (4%), and progressive disease in two patients (2%). Four patients with complete remission relapsed after 6, 8, 8, and 15 months, one revealing reinfection by H pylori. Regression rate was higher in stage I1 disease compared with stage I2, as diagnosed by endoscopic ultrasound. Conclusion: The majority of patients with low grade gastric MALT lymphoma treated by exclusive H pylori eradication have a favourable long term outcome, offering a real chance of cure.Keywords
This publication has 33 references indexed in Scilit:
- Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: Results of a prospective, multicenter study comparing EUS with histopathologic stageGastrointestinal Endoscopy, 2002
- Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: Results of a prospective, multicenter study comparing EUS with histopathologic stageGastrointestinal Endoscopy, 2002
- Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pyloriGut, 2001
- Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatmentGut, 2001
- The World Health Organization Classification of Neoplasms of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting – Airlie House, Virginia, November, 1997The Hematology Journal, 2000
- Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibioticsGastroenterology, 1999
- Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 1995
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993
- High incidence of primary gastric lymphoma in northeastern ItalyThe Lancet, 1992
- Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?Journal of Clinical Pathology, 1989